Clinical trials
Phase 3 Dyslipidemias trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Kastle Therapeutics, LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| Takeda | 2 |
| 89bio, Inc. | 1 |
| Amarin Pharma Inc. | 1 |
| AstraZeneca | 1 |
| Carelon Research | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 22 |
| Hypercholesterolemia | 8 |
| Hyperlipidemias | 8 |
| Lipid Metabolism Disorders | 4 |
| Metabolic Diseases | 4 |
| Obesity | 4 |
| Cardiovascular Diseases | 3 |
| Genetic Diseases, Inborn | 3 |
| Hyperlipoproteinemia Type II | 3 |
| Hyperlipoproteinemias | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.